Modern Hypofractionation Schedules for Tangential Whole Breast Irradiation Decrease the Fraction Size-corrected Dose to the Heart

Clinical Oncology

Volumn 25, Issue 3, 2013, Pages 147-152

  Appelt, A L ^a,b   Vogelius, I R ^c   Bentzen, S M ^d  

^a LILLEBAELT HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Breast; Heart; Hypofractionation; Late cardiac toxicity; Linear quadratic model

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CARDIOTOXICITY; HEART DEATH; HUMAN; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RISK FACTOR;

BREAST NEOPLASMS; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEART; HEART DISEASES; HUMANS; MODELS, BIOLOGICAL; POSTOPERATIVE CARE; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84873085632     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2012.07.012     Document Type: Article

References (22)

1. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366:2087-2106.
2. Whelan T.J., Pignol J.P., Levine M.N., et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010, 362:513-520.
3. Yarnold J., Ashton A., Bliss J., et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 2005, 75:9-17.
4. Owen J.R., Ashton A., Bliss J.M., et al. Effect of radiotherapy fraction size on tumor control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 2006, 7:467-471.
5. Bentzen S.M., Agrawal R.K., Aird E.G., et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008, 9:331-341.
6. Bentzen S.M., Agrawal R.K., Aird E.G., et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008, 371:1098-1107.
7. Qi X.S., White J., Li X.A. Is α/β for breast cancer really low?. Radiother Oncol 2011, 100:282-288.
8. Khan A., Haffty B.G. Hypofractionation in adjuvant breast radiotherapy. Breast 2010, 19:168-171.
9. Smith B.D., Bentzen S.M., Correa C.R., et al. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys 2011, 81:59-68.
10. Bartelink H., Arriagada R. Hypofractionation in radiotherapy for breast cancer. Lancet 2008, 371:1050-1052.
11. Offersen B., Højris I., Overgaard M. Radiation-induced heart morbidity after adjuvant radiotherapy of early breast cancer - is it still an issue?. Radiother Oncol 2011, 100:157-159.
12. Lauk S., Rüth S., Trott K.R. The effects of dose-fractionation on radiation-induced heart disease in rats. Radiother Oncol 1987, 8:363-367.
13. Joiner M.C., Bentzen S.M. Fractionation: the linear-quadratic approach. Basic clinical radiobiology 2009, 102-119. Hodder Arnold, London. 4th ed. M.C. Joiner, A. van der Kogel (Eds.).
14. Paszat L.F., Mackillop W.J., Groome P.A., Schulze K., Holowaty E. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys 1999, 43:755-762.
15. Marhin W., Wai E., Tyldesley S. Impact of fraction size on cardiac mortality in women treated with tangential radiotherapy for localized breast cancer. Int J Radiat Oncol Biol Phys 2007, 69:483-489.
16. Lievens Y. Hypofractionated breast radiotherapy: financial and economic consequences. Breast 2010, 19:192-197.
17. Andratschke N., Maurer J., Molls M., Trott K.R. Late radiation-induced heart disease after radiotherapy. Clinical importance, radiobiological mechanisms and strategies of prevention. Radiother Oncol 2011, 100:160-166.
18. Taylor C. Radiation-related heart disease following treatment for breast cancer [abstract]. Radiother Oncol 2011, 99(Suppl. 1):S76.
19. Jin J.Y., Kong F.M., Chetty I.J., et al. Impact of fraction size on lung radiation toxicity: hypofractionation may be beneficial in dose escalation of radiotherapy for lung cancers. Int J Radiat Oncol Biol Phys 2010, 76:782-788.
20. Vogelius I.S., Westerly D.C., Cannon G.M., Bentzen S.M. Hypofractionation does not increase radiation pneumonitis risk with modern conformal radiation delivery techniques. Acta Oncol 2010, 49:1052-1057.
21. Mizuta M, Takao S, Date H, et al. A mathematical study to select fractionation regimen based on physical dose distribution and the linear-quadratic model. Int J Radiat Oncol Biol Phys, doi:10.1016/j.ijrobp.2012.01.004.
22. Gagliardi G., Constine L.S., Moiseenko V., et al. Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys 2010, 76(Suppl. 3):S77-S85.